J-Pharma (TKS: 520A)

Tokyo, Japan · Founded 2005 · Publicly Held

J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. J-Pharma (TKS: 520A) is based in Tokyo, Japan and was founded in 2005. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $99.4 million (Mar 2026). It has raised $83.1 million.

Last price · $/share

—

Implied valuation

$99.4M

Total raised

$83.1M

Last round

—

How much has J-Pharma (TKS: 520A) raised?

$83.1Macross 0 recorded rounds

Free account

More of J-Pharma (TKS: 520A) with a free account

·The complete investor list: 30 names
·Watch J-Pharma (TKS: 520A): the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

J-Pharma (TKS: 520A) investors

30 investors are on record for J-Pharma (TKS: 520A), including Mitsubishi UFJ Capital, F-Prime Capital, Eight Roads and Japan External Trade Organization. By type, the record holds 4 venture capital firms and 1 asset manager.

For fundraisers

Raising for a company like J-Pharma (TKS: 520A)?

30 investors have backed J-Pharma (TKS: 520A).

See all 30 investors →

Frequently asked about J-Pharma (TKS: 520A)

How much has J-Pharma (TKS: 520A) raised?: J-Pharma (TKS: 520A) has raised $83.1M in total across 0 recorded funding rounds.